Filing Flows › Comparisons › DCTH vs RCEL
Delcath Systems vs Avita Medical: DCTH and RCEL compared
Delcath Systems is the larger company: $29.1M of revenue in its latest quarter (Q2 2026) against $26.1M for Avita Medical (Q3 2026). Avita Medical is growing faster (+53% against +21% a year earlier). Delcath Systems is more profitable, with an operating margin of 8.2% against -10.1%.
Where the money goes: DCTH and RCEL
Delcath Systems (DCTH) · Q2 2026
Delcath Systems, Q2 2026: revenue $29.1M (+21% year over year), operating margin 8.2%, net earnings $2.7M, operating cash flow $5.7M. The chart follows the revenue to costs, profit and cash.
Avita Medical (RCEL) · Q3 2026
Avita Medical, Q3 2026: revenue $26.1M (+53% year over year), operating margin -10.1%, net loss $6.2M, operating cash flow −$710K. The chart follows the revenue to costs, profit and cash.
| Delcath Systems (DCTH) | Avita Medical (RCEL) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $29.1M | $26.1M |
| Revenue growth, Y/Y | +21% | +53% |
| Gross margin | 89.8% | — |
| Operating margin | 8.2% | -10.1% |
| Net earnings | $2.7M | −$6.2M |
| Net margin | 9.2% | -23.8% |
| Operating cash flow | $5.7M | −$710K |
| Free cash flow | $5.2M | — |
Where the revenue comes from
Delcath Systems
- HEPZATO KIT: $27.2M (93%)
- CHEMOSAT: $2.0M (7%)
Questions
Which is bigger, Delcath Systems or Avita Medical?
Delcath Systems is the larger company: $29.1M of revenue in its latest quarter (Q2 2026) against $26.1M for Avita Medical (Q3 2026).
Is Delcath Systems or Avita Medical growing faster?
Avita Medical is growing faster (+53% against +21% a year earlier).
Which is more profitable, Delcath Systems or Avita Medical?
Delcath Systems is more profitable, with an operating margin of 8.2% against -10.1%.
More: Delcath Systems earnings · how Delcath Systems makes money · Avita Medical earnings · how Avita Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.